Esbriet 267 mg (Pirfenidone TABLET) 267 MG

ESBRIET 267 MG tablets contain pirfenidone, a medication used to manage certain lung conditions. This oral treatment is designed to support respiratory health and is available in a 267 mg strength.

Strength

267 MG

Pack Size

21/42/270

Manufacturer / TM Owner

HOFFMANN-LA ROCHE LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ESBRIET 267 MG tablets are primarily used to support lung health in conditions that affect breathing. Pirfenidone, the active ingredient, is often prescribed for its potential benefits in managing symptoms related to respiratory issues. Users may seek ESBRIET for its role in maintaining lung function and alleviating discomfort associated with breathing difficulties.

Side Effects

Common effects of ESBRIET 267 MG tablets may include gastrointestinal discomfort, nausea, or dizziness. Some users report experiencing fatigue or skin sensitivity. These effects can vary and are not experienced by everyone who takes the medication.

Precautions & Warnings

ESBRIET 267 MG tablets should be handled with care, especially in individuals with known allergies to pirfenidone. It is important to follow the advice of a healthcare provider regarding the use of this medication. Store the tablets in a cool, dry place away from direct sunlight.

Avoid Interactions

ESBRIET 267 MG tablets may interact with certain medications, including those metabolized by the liver. Alcohol consumption should be avoided while taking pirfenidone. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

ESBRIET 267 MG tablets are used to support lung health in conditions that affect breathing.

Store ESBRIET 267 MG tablets in a cool, dry place away from direct sunlight.

Common effects may include gastrointestinal discomfort, nausea, dizziness, fatigue, or skin sensitivity.

It is recommended to avoid alcohol while taking ESBRIET 267 MG tablets.

If you experience side effects, consult your healthcare provider for advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.